NASDAQ$OPCH
Option Care Health, Inc · Q3 2024 earnings
Q3 2024 earnings · · Investor relations
Briefing
Option Care Health's financial performance remained strong, marked by revenue growth and strategic financial management.
Option Care Health reported a 17.0% increase in net revenue to $1,278.5 million for the third quarter of 2024. Net income was $53.9 million, or $0.31 per diluted share, while adjusted EBITDA reached $115.6 million. The company faces supply chain disruptions expected to negatively impact fourth-quarter results.
- Net revenue increased by 17.0% year-over-year, reaching $1,278.5 million.
- Gross profit reached $256.7 million, representing 20.1% of net revenue.
- Net income was $53.9 million, with diluted earnings per share at $0.31.
- Adjusted EBITDA increased to $115.6 million, a 5.3% increase compared to the previous year.
Headline financials
Revenue & EPS history
Option Care Health · Revenue · Quarterly
$1.28B
Forward guidance
Option Care Health updated its full-year 2024 financial guidance, projecting net revenue between $4.9 billion and $4.95 billion and adjusted EBITDA between $438 million and $443 million. The guidance considers the negative impact of supply chain disruptions.
Tailwinds
- Net revenue is expected to be between $4.9 billion and $4.95 billion.
- Adjusted EBITDA is projected to be between $438 million and $443 million.
- Cash flow from operations is expected to be at least $300 million.
- The effective tax rate is projected to be between 26% and 28%.
- Net interest expense is expected to be approximately $55 million to $60 million.
Headwinds
- Supply chain disruption related to intravenous solution bags is expected to negatively impact fourth-quarter financial results.
- The company is unable to provide specific expectations on the timing of the ultimate resolution of the supply chain impact.
- The disruption primarily affects the portfolio of acute therapies.
- The company is actively monitoring the situation and collaborating with manufacturers and distributors.
- The updated guidance reflects the expected negative impact from the supply chain issues.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2024
-1.9%
Avg return
Earnings day
-4.2%
Avg return
5 days after
-1.9%
Avg return
30 days after
50%
36 / 72 earnings
Positive
+27.4%
Q3 2015
Best reaction
-53.6%
Q3 2016
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -24.3% | -20.7% | -22.4% | |
| Q4 2025 | -7.3% | -10.1% | -23.1% | |
| Q3 2025 | -8.7% | -5.7% | +8.5% | |
| Q1 2025 | -6.9% | -0.1% | -2.2% | |
| Q4 2024 | +1.6% | +4.1% | +6.4% | |
| Q3 2024 | -24.5% | -26.3% | -22.0% | |
| Q2 2024 | -1.9% | -5.3% | +2.1% | |
| Q1 2024 | -1.6% | -2.6% | -6.0% | |
| Q4 2023 | -3.4% | -1.8% | -2.0% | |
| Q3 2023 | -15.6% | -18.4% | -8.1% | |
| Q2 2023 | +5.3% | +4.0% | +7.9% | |
| Q1 2023 | -14.7% | -12.6% | -11.4% | |
| Q4 2022 | +7.1% | +6.3% | +9.4% | |
| Q3 2022 | -10.9% | -13.3% | -17.6% | |
| Q2 2022 | +5.0% | +4.8% | -2.2% | |
| Q1 2022 | +10.3% | +7.4% | +14.2% | |
| Q4 2021 | +8.6% | +10.8% | +20.9% | |
| Q3 2021 | -0.0% | -2.1% | -12.1% | |
| Q2 2021 | -0.1% | +8.3% | +35.1% | |
| Q1 2021 | -4.7% | -8.8% | +2.3% | |
| Q4 2020 | +2.2% | +1.9% | -3.7% | |
| Q3 2020 | +11.4% | +11.7% | +14.1% | |
| Q2 2020 | +3.6% | +1.7% | -2.8% | |
| Q1 2020 | +8.8% | +6.6% | +32.7% | |
| Q4 2019 | -12.8% | -16.1% | -48.4% | |
| Q3 2019 | -2.4% | -5.9% | -16.3% | |
| Q2 2019 | -1.4% | -5.2% | +21.5% | |
| Q1 2019 | -2.5% | -1.5% | -4.0% | |
| Q4 2018 | -33.0% | -38.7% | -50.4% | |
| Q3 2018 | +16.0% | +12.8% | +34.2% | |
| Q2 2018 | -1.5% | +2.5% | +4.4% | |
| Q1 2018 | -6.1% | -0.4% | +6.9% | |
| Q4 2017 | +3.3% | +0.0% | +9.8% | |
| Q3 2017 | -13.8% | -18.8% | +5.8% | |
| Q2 2017 | +8.6% | +21.8% | +6.8% | |
| Q1 2017 | +3.6% | +1.8% | +24.2% | |
| Q4 2016 | -12.3% | -10.6% | -33.9% | |
| Q3 2016 | -53.6% | -47.9% | -56.3% | |
| Q2 2016 | +3.0% | +2.6% | +2.3% | |
| Q1 2016 | +3.1% | — | — | |
| Q4 2015 | +7.1% | — | — | |
| Q3 2015 | +27.4% | — | — | |
| Q2 2015 | -22.8% | — | — | |
| Q1 2015 | -10.0% | — | — | |
| Q4 2014 | -11.3% | — | — | |
| Q3 2014 | +1.3% | — | — | |
| Q2 2014 | -4.4% | — | — | |
| Q1 2014 | +2.1% | — | — | |
| Q4 2013 | +6.3% | — | — | |
| Q2 1997 | +9.0% | — | — | |
| Q3 2013 | -4.6% | — | — | |
| Q2 2013 | -17.2% | — | — | |
| Q1 2013 | -0.1% | — | — | |
| Q4 2012 | -1.5% | — | — | |
| Q3 2012 | +3.7% | — | — | |
| Q2 2012 | +11.0% | — | — | |
| Q1 2012 | +3.2% | — | — | |
| Q4 2011 | -1.5% | — | — | |
| Q3 2011 | -11.2% | — | — | |
| Q2 2011 | +1.5% | — | — | |
| Q4 2010 | +1.5% | — | — | |
| Q1 2011 | -1.4% | — | — | |
| Q3 2010 | +8.1% | — | — | |
| Q2 2010 | -3.0% | — | — | |
| Q1 2009 | +0.9% | — | — | |
| Q1 2010 | +3.4% | — | — | |
| Q2 2009 | +2.6% | — | — | |
| Q4 2007 | +2.6% | — | — | |
| Q4 2009 | +2.6% | — | — | |
| Q3 2009 | +5.6% | — | — | |
| Q3 2008 | +5.6% | — | — | |
| Q4 2008 | +5.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro